PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Generic Infectious Disease Pharmaceuticals Offer Potential in Sub-Saharan Africa - The markets for generic infectious disease pharmaceuticals in sub-Saharan Africa hold considerable potential
Generic Infectious Disease Pharmaceuticals Offer Potential in Sub-Saharan Africa

 

NewswireToday - /newswire/ - Cape Town, South Africa, 2008/03/13 - The markets for generic infectious disease pharmaceuticals in sub-Saharan Africa hold considerable potential.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Despite high levels of poverty and market price sensitivity, the region has a large and growing population that is increasingly able to pay for better health services and pharmaceutical products.

New analysis from growth consulting company Frost & Sullivan (pharma.frost.com) finds that the Infectious Disease Pharmaceutical Markets in Key Sub-Saharan African Countries earned revenues of $403.2 million in 2006 and estimates this to reach $691.4 million in 2012.

"The infectious disease pharmaceuticals markets in Nigeria, Kenya and Tanzania are in a growth stage," notes Frost & Sullivan Research Analyst Tiwonge Mkandawire. "This is a result not only of government expansion of treatment programmes, but also a general increase in demand due to improving economic conditions."

The large and growing population in the region provides a suitable base for the distribution of sizeable volumes of infectious disease pharmaceuticals. International donor organisations have committed themselves to providing support for the expansion of HIV and malaria treatment programmes in Kenya, Tanzania and Nigeria. Such increases in donor funding are acting as key drivers in the growth of these markets.

Price sensitivity because of the high levels of poverty is however restraining the distribution of branded products. This is exacerbated by governmental regulations that allow compulsory licensing and parallel importation as a means of controlling the cost of medicines in the region.

"Counterfeit pharmaceuticals pose considerable competition to legal products," comments Mkandawire. "Despite efforts by relevant drug regulatory authorities to control them, counterfeit products still constitute a challenge. In some cases, the value of these illegal drug markets is as much as that of the legal markets."

Price sensitivity and the general preference for low-cost products by both public and private sector end users, are increasing the demand for generic pharmaceuticals. Accordingly, pharmaceutical companies will benefit from establishing plants or distribution points in regional economic hubs, such as Kenya and Nigeria. These can then be used as focal points for the distribution of generic pharmaceuticals into surrounding countries.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the investment analysis and growth opportunities in the Infectious Disease Pharmaceutical Markets in Key Sub-Saharan African Countries, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com, with your full name, company name, title, telephone number, fax number, and email address. Upon receipt of the above information, an overview will be sent to you by email.

Infectious Disease Pharmaceutical Market in Key Sub-Saharan African Countries is part of the Pharmaceutical and Biotechnology Growth Partnership Service Programme, which also includes research in the following markets: strategic assessment of the healthcare industry in key Sub-Saharan African countries, the regulatory environment for pharmaceutical products and medical devices in key Sub-Saharan African countries and strategic analysis of the oncology services market in Sub-Saharan Africa. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

Infectious Disease Pharmaceutical Markets in Key Sub-Saharan African Countries - M1A5

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Generic Infectious Disease Pharmaceuticals Offer Potential in Sub-Saharan Africa

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Patrick Cairns 
+27 21 680 3274 patrick.cairns[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)